SciBase

Swedish Melanoma Detection Device To Be Piloted at Dallas-Area Bare Dermatology Clinics

by | Sep 25, 2023
Stockholm-based SciBase has begun piloting its FDA-approved Nevisense device in the U.S.—starting in sun-splashed markets like North Texas, Florida, and other areas "where melanoma rates are high."
MORE